Future Health Stocks

Health and life sciences news releases, as the companies issue them.

All releases

26 recent releases from TMX Newsfile, newest first, refreshed every 5 minutes. This list follows a fixed rule; nothing in it is chosen, ranked or paid for. Times are Eastern.

14 of 26 shown on CSE. Clear

Monday, November 9, 2026

  1. Quinsam Capital CorporationCSE: QCATMX Newsfile

    Quinsam Announces Q3/2026 Results

    Quinsam is announcing its Q3/2026 results, with net income of $0.1 million ($0.001 per share basic, $0.001 fully diluted) versus net income of $0.1 million ($0.001 per share basic, $0.001 fully diluted) in Q3/2025.…

  2. Rhelion Life Sciences Corp.CSE: RHELFSE: 4YX0OTCQB: TRUFFTMX Newsfile

    Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Ships PEX010 to King's College London

    Rhelion an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"), the Company develops, manufactures and…

Friday, November 6, 2026

  1. Psyched Wellness Ltd.CSE: PSYCTMX Newsfile

    Psyched Wellness Announces Secured Term Loan

    Psyched Wellness Ltd. (OTCID: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products…

Thursday, November 5, 2026

  1. Doseology Sciences Inc.CSE: MOODOTCQB: DOSEFFSE: VU70TMX Newsfile

    Doseology Announces Revocation of MCTO and Adoption of Semi-Annual Financial Reporting

    Doseology announces revocation of the management cease trade order ("MCTO") previously issued on October 29, 2026; and its intention to voluntarily adopt the Semi-Annual Reporting ("SAR") Pilot Program pursuant to…

  2. Digicann Ventures Inc.CSE: DCNN.XTMX Newsfile

    Digicann Ventures Signs Definitive Share Exchange Agreement with Winning Asia Technology Macau Limited for Proposed Reverse Takeover Transaction

    Digicann is pleased to announce that, further to its news release dated June 5, 2026, it has entered into a binding share exchange agreement (the "Definitive Agreement") dated October 31, 2026 and signed on November 4…

Tuesday, November 3, 2026

  1. CSE: RHELFSE: 4YXOTCQB: TRUFFTMX Newsfile

    Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Ships PEX010 to the University of Southern California for the Expanded Mindfulness Assisted Psychedelic Therapy Trial

    Rhelion an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"),…

  2. CSE: VEXTTMX Newsfile

    Vext Reports Q3 2026 Financial Results; Record Quarterly Revenue of $14.9 Million; Operating Cash Flow of $2.4 Million

    Record quarterly revenue of $14.9 million, up 23% from Q2 2026 and 18% year-over-year. Ohio revenue up 37% year-over-year to $10.9 million, led by Fairfield and Company-grown flower. Operating cash flow of $2.4 million…

  3. Herbal Dispatch Inc.CSE: HERBOTCQB: LUFFFFSE: HA9TMX Newsfile

    Herbal Dispatch Accelerates Veteran Program Growth and Expands Access with New Clinic Partnership

    Herbal Dispatch, a cannabis commerce and international distribution platform, today issued a progress report on Hero Dispatch (herodispatch.com), the Company's medical cannabis program for Canadian Veterans, and…

Monday, November 2, 2026

  1. Neural Therapeutics Inc.CSE: NURLFSE: HANFTMX Newsfile

    Neural Therapeutics Provides Corporate Update

    Neural announces a change to its Board of Directors and provides updates regarding its previously announced transaction with CWE European Holdings Inc. ("CWE").Board of DirectorsThe Company announces that John Durfy has…

  2. CSE: RHELFSE: 4YX0OTCQB: TRUFFTMX Newsfile

    Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Completes New Extraction of IBEX011, Its Naturally Derived Ibogaine Drug Candidate, and Commences Stability Testing

    Rhelion, an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"), the Company develops, manufactures and…

Thursday, October 29, 2026

  1. Doseology Sciences Inc.CSE: MOODOTCQB: DOSEFFSE: VU70TMX Newsfile

    Doseology Announces Management Cease Trade Order for Late Filing of Annual Audited Financial Statements

    Doseology, a consumer product innovation company focused on oral pouch and functional stimulant product technologies, announces that it was unable to file its annual audited financial statements, management's discussion…

Wednesday, October 28, 2026

  1. CSE: RHELFSE: 4YX0OTCQB: TRUFFTMX Newsfile

    Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Agreement to Supply PEX010 to Linkoping University for PsiloSAD Trial in Social Anxiety Disorder

    Rhelion an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"), the Company…

Friday, October 16, 2026

  1. CSE: RHELFSE: 4YX0OTCQB: TRUFFTMX Newsfile

    Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health to Supply Belgium's First Psilocybin Compassionate Use Program, to Help Open the Door to Patient Access for Treatment-Resistant Depression

    Rhelion an Ontario-based organization advancing…

Wednesday, October 14, 2026

  1. Doseology Sciences Inc.CSE: MOODOTCQB: DOSEFFSE: VU70TMX Newsfile

    Doseology Announces Resignation of Director

    Doseology a consumer product innovation company focused on oral pouch and functional stimulant product technologies, announces that Larry Latowsky has resigned as a director of the Company, effective immediately. About…